Trial news

Click here to read more about OCTOPUS at the MS Frontiers conference in July held at Liverpool.

We have now reached 277 participants randomised and 375 participants screened meaning we have recruited 74% of our goal for analysis stage 1 (375)!

Asian MS: OCTOPUS and diversity in clinical trials webinar

We have now reached 245 participants randomised and 303 participants screened meaning we have recruited 65% of our goal for analysis stage 1 (375)!

So far:

• 13 hospital sites are open and actively contacting potential participants.
• 413 potential participants have been through telephone screening by their chosen site.
• 296 have attended their chosen hospital site for further screening and to give consent.
• 241 participants have entered the Octopus trial and started trial treatment.
• Another 134 participants will start treatment on the Octopus trial by December 2024 – to reach the goal of 375 participants in this first stage of the trial.